What Is an HCPCS Code? A Practical Guide for Device Makers
2026-09-18 · Caduvo Team
Learn what an HCPCS code is, how Level II codes control payment for medical devices and DME, and how to navigate the CMS MEARIS application cycle.
Securing FDA clearance brings your medical device to the starting line, but clearance alone does not get a claim paid. If your technology is durable medical equipment (DME), a prosthetic, an orthotic, or a medical supply used outside an inpatient hospital stay, Medicare contractors and commercial insurers require a standardized code to process payment. That billing identifier is a Healthcare Common Procedure Coding System (HCPCS) code. Without an appropriate code, suppliers cannot submit standard electronic claims for your product, stalling commercial adoption.
Understanding what is a hcpcs code—and how Level II item codes differ from physician procedure codes—is essential when planning your market launch. This guide breaks down the structure of HCPCS Level II codes, the operational distinction between coding and payment, the CMS application cycle through MEARIS™, and the regulatory mechanics of billing under miscellaneous codes while an application is pending.
HCPCS Level I vs Level II: Two Different Systems
Health insurers across the United States process over five billion claims every year. To manage that volume, the federal government established standardized medical code sets under 45 CFR 162.1002 to execute Health Insurance Portability and Accountability Act (HIPAA) requirements. Regulations published on August 17, 2000 (65 FR 50312) eliminated local "Level III" codes by October 2002, leaving two principal national subsystems:
- HCPCS Level I (CPT® Codes): Maintained and copyrighted by the American Medical Association (AMA), Level I consists of Current Procedural Terminology codes. These five-digit numeric codes are used primarily by physicians and other healthcare professionals to bill diagnostic procedures, evaluations, and surgical services. If you are comparing procedural billing against device billing, see our guide on HCPCS vs CPT codes.
- HCPCS Level II Codes: Maintained by CMS under authority delegated by the Department of Health and Human Services (HHS) in 2003 under 42 CFR 414.40(a), as detailed in CMS HCPCS General Information guidance. These alphanumeric codes consist of a single alphabetical letter followed by four numeric digits.
While CPT codes identify medical procedures performed by clinicians, hcpcs level ii codes identify the actual items, supplies, and non-physician services furnished to patients. Level II codes cover products that fall outside CPT jurisdiction, such as durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS) when used outside a physician's office, as well as ambulance services, drugs, and biologicals.
According to the HCPCS Release & Code Sets guidance, Level II alphanumeric procedure and modifier codes span the A to V character range. Within the national hcpcs codes list, each code represents a category of items or services rather than an individual commercial brand, ensuring standard processing across Medicare, Medicaid, and private payers.
Why a Code Is the Gateway to Payment (and Why It Isn't Enough)
Device teams often assume that securing an HCPCS Level II code guarantees insurance reimbursement. CMS dispels this assumption in its published HCPCS Level II Coding Procedures: HCPCS Level II is strictly a system for identifying items and certain services. It is not a methodology or system for making coverage or payment determinations, and the existence of a code does not determine coverage or non-coverage for an item or service.
Commercializing a new medical device requires clearing three distinct administrative hurdles:
- Coding: An active alphanumeric code must exist on the claim so payer software can intake and classify the transaction.
- Coverage: The payer must confirm that the item fits a defined statutory benefit category under Part A or Part B and meets medical necessity standards. Under §1862(a)(1)(A) of the Social Security Act, Medicare covers items only if they are reasonable and necessary for diagnosis, treatment, or functional improvement. Read our overview of how medical device reimbursement works to evaluate benefit categories.
- Payment: A reimbursement rate must attach to that code. For most Medicare fee-for-service payment systems, rates are generally adjusted on an annual basis and reflect the average costs to provide a service based on the most recently available Medicare data or the Consumer Price Index for All Urban Consumers (CPI-U), according to the CMS Guide for Medical Technology Companies. Understanding how payers price equipment is central to your commercialization plan; see our review of Medicare DME fee schedule billing.
A code is a prerequisite for electronic billing. Without an assigned code, contracted DMEPOS suppliers cannot bill the item through standard automated channels, creating administrative barriers that discourage distributors from carrying your device.
The CMS Application Cycle and MEARIS Submission Rules
CMS manages external requests to add, revise, or discontinue HCPCS Level II codes through the Medicare Electronic Application Request Information System (MEARIS™). Any stakeholder can submit an application, but CMS subjects every filing to rigid eligibility criteria.
Filing Schedules and Deadlines
CMS separates coding reviews into two distinct operating cycles:
- Drugs and biological products: Reviewed quarterly, with applications due on the first business day of January, April, July, and October.
- Non-drug and non-biological items and services: Reviewed biannually, with applications due on the first business day of January and the first business day of July.
Under 42 CFR 49507 (established October 31, 2025), effective January 1, 2026, CMS reviews complete coding applications for Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps), skin substitutes cleared through a 510(k) clearance, and skin substitutes approved under Premarket Approval (PMA) in the biannual non-drug and non-biological coding cycles. These products face the January and July deadlines and must participate in the established public meeting process.
Evaluation Gates: Tier 1 and Tier 2
CMS screens external submissions using the two-stage evaluation framework defined in the CMS HCPCS Decision Tree and Definitions.
Tier 1: Basic Admissibility Criteria
- Timeliness and completeness: Complete applications received by the deadline enter that cycle. Applications received after the deadline roll to the subsequent cycle; incomplete filings must be resubmitted.
- Code jurisdiction: The item cannot fall within the scope of CPT, dental (CDT), or inpatient hospital (ICD-10-PCS) systems. It cannot be hospital capital equipment or an item used exclusively in an inpatient setting.
- Primarily medical in nature: The product must serve a diagnostic or therapeutic purpose and have no practical utility in the absence of an illness or injury.
- FDA market authorization: Regulated items must possess final FDA clearance or approval before the application deadline. While CMS grants drug applications up to 90 days after the deadline to supply FDA approval documentation, non-drug devices enjoy no grace period.
- National programmatic need: At least one insurance sector—public (Medicare or Medicaid) or commercial payers—must have an operating need to identify the item separately at a national level.
Tier 2: Clinical Differentiation and Marketing Data When an existing code category describes similar items, CMS evaluates whether your product performs a significantly different function (e.g., dynamic versus static, swing versus stance) or operates through a different mechanism (e.g., electronic versus mechanical, automatic versus manual regulation).
If the product performs a function comparable to existing codes, CMS creates a new code only if clinical literature establishes a significant therapeutic distinction—a verified, superior medical outcome over previously coded items. In addition, CMS requires non-drug applicants to demonstrate at least 3 months of commercial marketing activity in the United States prior to code creation. This marketing threshold ensures administrative code creation supports active commercial trade rather than hypothetical market entries.
Caduvo helps MedTech market-access teams evaluate existing Level II descriptors and CMS coding decisions, verifying whether clinical evidence supports a Tier 2 distinction before filing through MEARIS™.
What to Do When Your Device Has No Dedicated Code: Miscellaneous Codes
Because CMS establishes coding determinations on a biannual cycle for non-drug items and requires evidence of at least 3 months of commercial marketing activity, new devices often enter the commercial market without a dedicated HCPCS Level II code. In the HCPCS Decision Tree and Definitions, CMS establishes that when an external request does not result in a new or revised code, applicants are directed to use an existing code or use a miscellaneous code, subject to a national program operating need.
Historically, before HIPAA regulations eliminated local Level III codes, insurers established local codes when they preferred suppliers to avoid using a 'miscellaneous or not otherwise classified code,' as outlined in CMS HCPCS Level II Coding Procedures history. Today, suppliers rely on national miscellaneous codes such as E1399 (Durable medical equipment, miscellaneous) to bill non-drug items that lack a specific Level II descriptor.
However, operating under a miscellaneous code requires deliberate planning. According to published reimbursement strategy guidance, providers, suppliers, and manufacturers are responsible for case-by-case assessment, documentation, and justification of medical necessity. In addition, as emphasized in peer-reviewed guidance on the HCPCS process, planning for an HCPCS code should take place well in advance of submission, with reimbursement staff involved early during product research and clinical trial discussions. Device teams must determine whether an existing code applies or assemble evidence to participate in the HCPCS public meeting process to seek a new code.
Actionable Takeaways for Device Manufacturers
- Confirm code jurisdiction before preparing an application: Verify your product falls outside CPT procedural billing and hospital inpatient codes before submitting an HCPCS Level II request.
- Audit existing descriptors first: If an existing Level II descriptor fits your device, CMS directs suppliers to use that code; CMS will not create a new code unless the device performs a significantly different function or operates differently.
- Establish 3 months of commercial marketing: Non-drug applicants must provide documentation showing at least 3 months of active marketing history in the United States to satisfy CMS Tier 2 criteria.
- Track the biannual MEARIS™ deadlines: Non-drug code applications are due on the first business day of January and July. Missing the cutoff by one day delays your application to the subsequent coding cycle.
- Assemble comparative clinical evidence early: If your device performs a similar function to existing products, compile clinical data demonstrating a significant therapeutic distinction to support code creation.
- Plan for case-by-case necessity documentation: When billing under miscellaneous codes such as E1399 before securing a dedicated code, ensure suppliers have the documentation needed to support case-by-case justification of medical necessity.
Sources
- HCPCS Level II Coding Procedures | CMS
- Tips for Navigating the Healthcare Common Procedure Coding System Coding Process for New Devices
- HCPCS Coding: An Integral Part of Your Reimbursement Strategy
- Healthcare Common Procedure Coding System Level II Coding Procedures
- CMS Guide for Medical Technology Companies and Other Interested Parties | CMS
- HCPCS Decision Tree and Definitions
- HCPCS Release & Code Sets
- CMS HCPCS - General Information
General information, not regulatory, legal or reimbursement advice. Company and product names belong to their owners; a mention does not imply affiliation or endorsement. Report an error. Data and corrections policy.